LifeMD (LFMD) Notes Payables (2016 - 2024)
LifeMD's Notes Payables history spans 12 years, with the latest figure at $13000.0 for Q2 2024.
- For Q2 2024, Notes Payables fell 98.23% year-over-year to $13000.0; the TTM value through Jun 2024 reached $13000.0, down 98.23%, while the annual FY2023 figure was $217000.0, 92.24% down from the prior year.
- Notes Payables reached $13000.0 in Q2 2024 per LFMD's latest filing, down from $116.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $116.0 million in Q1 2024 to a low of $13000.0 in Q2 2024.
- Average Notes Payables over 5 years is $8.0 million, with a median of $637346.5 recorded in 2020.
- The largest YoY upside for Notes Payables was 6264.92% in 2024 against a maximum downside of 98.23% in 2024.
- A 5-year view of Notes Payables shows it stood at $779132.0 in 2020, then tumbled by 91.86% to $63400.0 in 2021, then skyrocketed by 4312.07% to $2.8 million in 2022, then crashed by 92.24% to $217000.0 in 2023, then plummeted by 94.01% to $13000.0 in 2024.
- Per Business Quant, the three most recent readings for LFMD's Notes Payables are $13000.0 (Q2 2024), $116.0 million (Q1 2024), and $217000.0 (Q4 2023).